國家衛生研究院 NHRI:Item 3990099045/13430
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 856873      線上人數 : 951
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/13430


    題名: Targeting RSPO3 reduces stem cell function in RSPO3-Fusion-positive colon cancer and RSPO3 high lung cancer
    作者: Hung, HC;Yen, WC;Chang, TY;Yen, GJ;Huang, CT;Fang, MY;Lai, YL;Tsai, YR;Chen, CT;Shih, C;Hsu, TA
    貢獻者: Institute of Biotechnology and Pharmaceutical Research
    摘要: Recent studies have revealed that the R-spondins (RSPOs) can mediate with Lgr4 and Lgr5 proteins/Frizzled/LRP receptor complexes as an independent (noncanonical) control of the Wnt pathway. Several lines of evidence supported that RSPOs play a positive role in the regulation of Wnt/beta-catenin signalling. We have identified an anti-RSPO3 antibody (DBPR117; hB1) using a rational design approach. DBPR117 was identified as an ideal candidate to be developed as a therapeutic antibody. DBPR117 was well characterized in a variety of assays including the binding assays, in vitro bioassays, in vivo PDX (patient-derived xenograft), lung cancer or colon cancer CDX (cell line-derived xenograft) models. DBPR117 is capable of binding specifically to the human RSPO3 with novel amino acid sequences in the complementary determining regions (CDRs). DBPR117 showed efficacy in human colon and lung cancers with RSPO3 fusion/overexpression. We are currently evaluating whether antagonizing RSPO3 by DBPR117 would synergize with anti-PD-L1 antibody to combat cancers using syngeneic murine models.
    日期: 2018-12
    關聯: Cancer Science. 2018 Dec;109(Suppl. 2, SI):1257.
    Link to: https://doi.org/10.1111/cas.13904
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1349-7006&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000453773606099
    顯示於類別:[徐祖安] 會議論文/會議摘要
    [石全(2014-2017)] 會議論文/會議摘要
    [陳炯東] 會議論文/會議摘要
    [顏婉菁] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000453773606099.pdf15KbAdobe PDF200檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋